FDA Investigator Lisa K Capron

Lisa K Capron has inspections in 4 countries as of 20 Sep 2023. Lisa K Capron has collaborated with a combinined 5087 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
131
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Denmark, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Abby M Miller, Alan D Grupe, Alan P Kurtzberg, Albert A Salvador, Alexander M Kay, Alexandra B Pitkin, Alicia A Borg Borm, Amanda L Fyles, Amy R Glynn, Andrew "Drew" Haack, PhD, Andrew Haack, PhD, Andrew K Haack, PhD, Angela Shepas, Anissa M Vargas, Anita Narula, PhD, Annette L Diggs, Arsen Karapetyan, Ashar P Parikh, Astrida B Mattson, Barbara J Rincon, Barbara Janine Breithaupt, Barbara R Pfrunder, Belinda E Clifton, Bowman, Bradley Dworak, PhD, Brenda K Alford, Brenda L Reihing, Brian Janelsins, PhD, Bruce R Burrell, Bryce E Mansfield, Camille Bennett Hoffman, Carl A Anderson, Carr Sharpe, Carrie A Hughes, Caryn M Mcnab, Catherine J Laufmann, CDR Donald Ertel, Celia L Hutchinstein, Celia L Silverstein, Charles Yuanchia Kuo, PhD, Chava Kimchi Sarfaty, PhD, Chiaochun J Wang, Christian D Lynch (CDL), Christine A Harman, PhD, Christopher R Czajka, Clinton R Vanblaricom, Colleen M Aspinwall, Connie P Rezendes, Connie P Rezenes, Craig K Hopkins, Crystal A Harlan, Crystal Monroy, Cynthia J Lee, MS, Dan C Fisher, David J Gomes, David L Hunsaker, David Y Hernandez, Dawn E Barkans, Deborah A Nebenzahl, Deborah M Trout, Debra J Fracassa, Dennis G Kawabata, Dennis R Hudson, Devon M Shoop, Dianne B Latona, Dirk L Lincoln, Dolores E Price, Don A Brunssen, Don H Bark, PhD, Donald B Mckechnie, Donald W Jehn, Dr. Gopa Biswas, PhD, Edwin Melendez, Eileen A Liu, Elizabeth A Sheller, Elizabeth C Ajuzie, Elizabeth S Howell, Ellen N Stewart, Eric C Milstead, Eric L Scott, Eric S Myskowski, Erika V Butler, Ethan P Stegman, Farhana Khan, Garciam, George Lunn, PhD, Gerard Pde Leon, Gina C Collins, Gloria J Baca, MS, Gordon T Wales, Graham N Giesen, Greg K Keshishyan, Gulshan R Anand, Hanna L Potter, Harmon M Blanch, Heika R Bounds, Heika R Tait, Henry E Carrillo, Hoover, Hugh A Grimoldby, Hugh Grimoldby, Hugh M Mcclure, II, Hughes, Huiquan Wu, Hung H Do, MS, Ian J Thomson, Jacqueline Mdiaz Albertini, James C Henry, James D Hildreth, James I Vik, James P Stallings, James S Cartwright, James S Stuart, BS, Jane M Kreis, Jason T Lovelady, Jean C Colon Lopez, Jeanne M Weishaar, Jeffrey J Leclair, Jeffrey P Raimondi, Jennifer A Hickey, Jennifer L Bridgewater, Jessica B Clark, Jessica L Kocian, Jinkee Mvila Binayug, Joan Johnson, Jocelyn E Massey, Joey V Quitania, John Burr, John Cook, John E Emmert, John T Sproul, John W Banks, Jonathan K Dare, Jonathan T Little, Joseph A Seitz, Joseph M Hudak, Judy C Nepsa, Julian C Hanson, Justin A Boyd, Ka L Wong, Kari M Johansen, Katharine Chan, Katherine L Arnold, Kathryn A Krentz, Kathryn E King, Kathryn M Mogen, Keegan B Mixon, Kelsey M Bishop, Kenneth O Gee, PhD, Kenneth S Boehnen, Kevin T Gerrity, Kimberly J Proctor Jones, Kimberly M Lichter, Ko U Min, Kristin M Abaonza, Lakecha N Lewis, Lance W Bohm, Laurel A Beer, Lauren E Swantko, Lawrence Y Lee, PhD, LCDR Debra Emerson, Leon R Marquart, Lesley A Swanson, Lilly O Barton, Linda S Leja, Lisa A Bowden, Lori J Silverstein, Lynda L Perry, PhD, Lynn L Wong, Mageet, Malinda C Shelman, Marcus A Goshen, Margo C Jones, Margo Cl Jones, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mariza M Jafary, Mark E Imsland, Mark E Moen, Mark L Collins, Mark W Babbitt, Marsha L Mccauley, Maxine H Wong, Melody M Ragasa Leong, Michael F Schuette, Michael J Donovan, Michael S Araneta, Mihaly S Ligmond, Mikel T Wright, Mikhail V Ovanesov, PhD, Minh D Phan, Mpris Inspector, Namcy E Byerly, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy E Doyle, Narahi J Alvarez Alcazar, Nataniel Phillips Sylvain, PhD, Nicholas L Hunt, Omotunde O Osunsanmi, Orval D Mcintire, Paul A Licata, Paul F Rader, Paul M Kawamoto, Paul Rader, Paula A Trost, Peter C Chow, Peter Kessler, PhD, Peter T Regan, Phillip J Sample, Prabhu P Raju, Rabia Ballica, PhD, Rachelle M Deskins, Randy L Self, Rebecca A Sletner, Rebecca Rodriguez, Rebecca T Davis, Richard A Martin, Richard G Runyon, Richard Ledwidge (nmi), PhD, Richard W Tubb, Riley C Myers, PhD, Riley Meyers, Robert A Williams, Robert C Hoover, Robert D Tollefsen, Robert J Vezzetti, Rocco C Black, Rochelle A Rolnik, Rocio Guzman Velazquez, Roger F Zabinski, Ronald E Gill, Rowena S Nguyen, S Lori Brown, PhD MPH, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sara H Gabel, Sara Jdent Acosta, Sarah A Hassas, Savini, Scott A Nabe, Scott W Fox, Sharon K Finley, Shelagh D Schopen, Sherri N Rohlf, MD, Sonia R Peterson, Sridhar Thumma, State Agency, Stephanie A Jameson, Stephen R Souza, Stuart Kim, Sundy V Sedwick, Sundy Ven, Sunitha K Rajaram, PhD, Susan F Laska, MS, Tara M Pianko, Teegan Dellibovi Ragheb, PhD, Terri L Dodds, Terry L Dodds, Thao T Kwan, Thomas C Mclean, CFS, Thomas J Arista, Thomas W Gordon, Timothy D Evans, Tina S Roecklein, Tracy K Li, Trushani T Desai, Uttaniti Limchumroon (Tom), V Teres Speer, Vanessa R Muller, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Vioela J Caze, Wayne D Stowell, Wayne E Seifert, Wayne F Larson, Wendy S Shenk, William A Burkey, William C Hughes, Willis L Hicks, Xiaojun Yan, Xing Wang, PhD, Xiomara Copeland, Yideng Liang, Young M Yoon, Yuan Chia Kuo, Zachary A Bogorad, Zachary L Stamm, Zhong Li, PhD

Lisa K Capron's Documents

Publish Date Document Type Title
March, 2003 FDA 483 Response Bridgeport Wholesale Products, Inc - Form 483R, 2003-04-03
February, 2016 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2016-02-26
September, 2003 FDA 483 Norco, Inc DBA Norco Medical - Form 483, 2003-09-11
May, 2006 EIR Jubilant HollisterStier LLC - EIR, 2006-05-12
March, 2003 EIR Bridgeport Wholesale Products, Inc - EIR, 2003-03-11
February, 2007 FDA 483 Sensaria LLC - Form 483, 2007-02-16
January, 2004 FDA 483 Smart Pharmaceuticals Inc - Form 483, 2004-01-21
March, 2003 FDA 483 Bridgeport Wholesale Products, Inc - Form 483, 2003-03-11
November, 2003 EIR Evergreen Pharmaceutical Inc. - EIR, 2003-11-18
February, 2008 FDA 483 Emerald Kalama Chemical, LLC - Form 483, 2008-02-28
August, 2007 EIR Paula M. Shaw, MD - EIR, 2007-08-10
November, 2003 EIR Biomedex, Inc. - EIR, 2003-11-20
December, 2003 FDA 483 Columbia Nutritional LLC - Form 483, 2003-12-19
December, 2004 FDA 483 HF Acquisition Co LLC - Form 483, 2004-12-14
March, 2005 FDA 483 Magno-Humphries, Inc. - Form 483, 2005-03-11
March, 2007 EIR Melaleuca - EIR, 2007-03-29
December, 2007 FDA 483 NuCel Lab Inc - Form 483, 2007-12-17
June, 2006 FDA 483 OFD Biopharma, LLC - Form 483, 2006-06-16
January, 2009 EIR LCG Bioscience - EIR, 2009-01-23
June, 2006 EIR OFD Biopharma, LLC - EIR, 2006-06-18
July, 2003 EIR Repaul Textiles, LLC - EIR, 2003-07-18
March, 2004 EIR Fred Hutchinson Research Center IRB - EIR, 2004-03-08
February, 2005 FDA 483 Sensaria LLC - Form 483, 2005-02-15
May, 2006 FDA 483 Jubilant HollisterStier LLC - Form 483, 2006-05-12
May, 2006 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2006-05-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more